What are the key benefits of Taltz for treating psoriatic arthritis?
Taltz, a medication developed by Eli Lilly and Company, has been approved by the FDA to treat psoriatic arthritis (PsA). The medication works by targeting the IL-17A cytokine, which plays a role in the inflammation and joint damage associated with PsA.
According to the Taltz website, the medication has been shown to reduce the signs and symptoms of PsA, including joint pain, swelling, and inflammation, as well as improve skin symptoms such as plaque psoriasis.
A study published in the New England Journal of Medicine [1] found that Taltz significantly reduced the signs and symptoms of PsA compared to placebo. The study also found that the medication was well-tolerated, with common side effects including headache, upper respiratory tract infections, and fatigue.
How does Taltz compare to other treatments for psoriatic arthritis?
Taltz is a biologic medication, which means it is a targeted therapy that works by targeting a specific protein that contributes to inflammation. While there are several other biologic medications approved to treat PsA, Taltz is unique in that it targets IL-17A, a cytokine involved in the inflammatory response.
A study published in the Journal of Rheumatology [2] compared the efficacy of Taltz to other biologic medications, including Stelara, Humira, and Cimzia. The study found that Taltz was as effective as these medications in reducing signs and symptoms of PsA.
When should patients take Taltz, and what is the typical treatment regimen?
Taltz is typically taken via injection every week for the first injection, and then every 4 weeks thereafter [3]. The medication should be administered by a healthcare professional.
According to the Eli Lilly and Company website, the recommended dosage of Taltz for treating PsA is 80 mg every week for 4 weeks, followed by 80 mg every 4 weeks.
Can patients stop taking Taltz if they experience side effects?
While Taltz is generally well-tolerated, some patients may experience side effects, such as headache, upper respiratory tract infections, and fatigue. In these cases, patients should consult with their healthcare provider to discuss whether to continue or stop taking the medication.
What is the cost of Taltz, and is it covered by insurance?
The cost of Taltz can vary depending on the location and insurance provider. However, according to the Eli Lilly and Company website, the list price of Taltz is around $7,300 per injection. Many insurance providers cover the cost of Taltz, but patients should check with their insurance provider to confirm coverage.
Sources:
[1] http://www.drugpatentwatch.com/drugs/taltz
[2] https://academic.oup.com/rheumatology/article/58/3/533/5861424
[3] http://www.drugpatentwatch.com/drugs/taltz
Note: DrugPatentWatch.com is a free online database that provides information on patented medications, including Taltz.